Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Kwang Rok Kim"'
Autor:
Byumseok Koh, Kwang Rok Kim
Publikováno v:
ACS Omega, Vol 4, Iss 12, Pp 15134-15138 (2019)
Externí odkaz:
https://doaj.org/article/210d8e8d44684853bf2550442fc60829
Encapsulation and Enhanced Delivery of Topoisomerase I Inhibitors in Functionalized Carbon Nanotubes
Autor:
Sieun Chae, Dahee Kim, Kyung-jin Lee, Dasol Lee, Young-O Kim, Yong Chae Jung, Sang Dal Rhee, Kwang Rok Kim, Jeong-O Lee, Sunjoo Ahn, Byumseok Koh
Publikováno v:
ACS Omega, Vol 3, Iss 6, Pp 5938-5945 (2018)
Externí odkaz:
https://doaj.org/article/d00cad212f984af4a59c8b89270e9675
Publikováno v:
Stem Cells International, Vol 2017 (2017)
Although transdifferentiation of mesenchymal stem cells (MSCs) into neurons increases the possibility of therapeutic use of MSCs for neurodevelopmental disorders, the use of MSCs has the limitation on differentiation efficiency to neuronal lineage an
Externí odkaz:
https://doaj.org/article/4101deaafe9b4e939185e1f936f77d5b
Autor:
Kwang Rok Kim, Gui Zhou
Publikováno v:
BUSINESS LAW REVIEW. 36:171-202
Autor:
Yuna Kim, Kwan-Young Jung, Yun Hak Kim, Pan Xu, Yunju Jo, Baeki E. Kang, Navin Pandit, Jeongho Kwon, Karim Gariani, Joanna Gariani, Junguee Lee, Jef Verbeek, Seungyoon Nam, Sung-Jin Bae, Ki-Tae Ha, Hyon-Seung Yi, Minho Shong, Kyun-Hwan Kim, Doyoun Kim, Chang-Woo Lee, Hee Jung Jung, Kwang Rok Kim, Kristina Schoonjans, Dongryeol Ryu, Johan Auwerx
The FDA-approved oral multi-kinase inhibitor, sorafenib (BAY 43-9006, Nexavar), is the first approved systemic therapy for patients with unresectable hepatocellular carcinoma (HCC). Although it has been shown to significantly improve the overall surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5095d70e825e4459d237e83991d7ae5
https://doi.org/10.1101/2023.03.13.531998
https://doi.org/10.1101/2023.03.13.531998
Autor:
Kwang-rok Kim, Yafei Ye
Publikováno v:
commercial cases review. 34:231-252
Autor:
Pengcheng Gao, Kwang Rok Kim
Publikováno v:
BUSINESS LAW REVIEW. 35:87-105
Autor:
Kwang-Rok Kim, Gui Zhou
Publikováno v:
BUSINESS LAW REVIEW. 34:185-219
Autor:
Kwang-rok Kim
Publikováno v:
commercial cases review. 33:191-236
Autor:
Kwang Rok Kim
Publikováno v:
LAW RESEARCH INSTITUTE CHUNGBUK NATIONAL UNIVERSITY. 31:39-65